The prostate, lung, colon, and ovarian (PLCO) cancer screening trial: Status and promise

Urologic Oncology: Seminars and Original Investigations - Tập 22 - Trang 358-361 - 2004
Gerald L Andriole1, Douglas Reding2, Richard B Hayes3, Philip C Prorok3, John K Gohagan3
1Division of Urologic Surgery, Washington University School of Medicine, Washington University in St. Louis, 4960 Children’s Place, Campus Box 8242, St. Louis, MO 63110, USA
2Marshfield Medical Research and Education Foundation, Marshfield, WI USA
3National Cancer Institute, Bethesda, MD USA

Tài liệu tham khảo

Gohagan, 2000, The Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial of the National Cancer Institute, Controlled Clinical Trials, 21, 251S, 10.1016/S0197-2456(00)00097-0 Hayes, 2000, Etiologic and early marker studies in the Prostate, Lung, Colorectal and Ovarian (OLCO) Cancer Screening Trial, Controlled Clinical Trials, 21, 349S, 10.1016/S0197-2456(00)00101-X Prorok, 2000, Design of the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial, Controlled Clinical Trials, 21, 273S, 10.1016/S0197-2456(00)00098-2 Lum, 1998, A simple mouthwash method for obtaining genomic DNA in molecular epidemiologic studies, Cancer Epidemiol Biomarkers Prev, 7, 719
Thông tin
Thông tin xuất bản

Urologic Oncology: Seminars and Original Investigations

Tập 22

358-361

Thông tin tác giả